JPMorgan Chase & Co. Sells 451,201 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS)

JPMorgan Chase & Co. lowered its position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 62.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 266,327 shares of the company's stock after selling 451,201 shares during the quarter. JPMorgan Chase & Co. owned 0.16% of Integral Ad Science worth $2,780,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of IAS. Jennison Associates LLC boosted its stake in Integral Ad Science by 3.3% in the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock valued at $663,000 after acquiring an additional 2,046 shares during the last quarter. Oppenheimer & Co. Inc. raised its holdings in shares of Integral Ad Science by 8.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock worth $293,000 after purchasing an additional 2,069 shares during the period. Arizona State Retirement System lifted its stake in Integral Ad Science by 12.5% in the fourth quarter. Arizona State Retirement System now owns 23,404 shares of the company's stock valued at $244,000 after purchasing an additional 2,601 shares during the last quarter. Victory Capital Management Inc. grew its holdings in Integral Ad Science by 8.9% during the fourth quarter. Victory Capital Management Inc. now owns 32,880 shares of the company's stock valued at $343,000 after purchasing an additional 2,695 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in Integral Ad Science by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 603,848 shares of the company's stock worth $6,304,000 after buying an additional 7,941 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Trading Up 0.9 %

Integral Ad Science stock opened at $6.44 on Wednesday. The stock has a market cap of $1.05 billion, a P/E ratio of 32.20, a PEG ratio of 1.06 and a beta of 1.53. Integral Ad Science Holding Corp. has a fifty-two week low of $6.26 and a fifty-two week high of $13.62. The firm's fifty day moving average price is $8.68 and its 200-day moving average price is $10.04. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $153.00 million during the quarter, compared to analysts' expectations of $148.83 million. During the same period in the previous year, the business earned $0.06 EPS. The business's revenue was up 13.9% on a year-over-year basis. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of the company's stock in a transaction that occurred on Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the completion of the sale, the chief executive officer now owns 341,271 shares of the company's stock, valued at $2,337,706.35. This represents a 2.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 90,303 shares of company stock valued at $706,660 in the last quarter. Corporate insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Scotiabank started coverage on Integral Ad Science in a research note on Friday, February 28th. They set a "sector perform" rating and a $12.00 price target for the company. Robert W. Baird reiterated a "neutral" rating and set a $9.00 target price (down previously from $16.00) on shares of Integral Ad Science in a research report on Friday, March 28th. Baird R W downgraded shares of Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research note on Friday, March 28th. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Finally, Morgan Stanley reduced their price objective on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $13.75.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.